Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
which one? Watertown? Somerville?
Check the WalMart there - I checked soon after the walmart CA PR and couldn't find WC in the paint section or with the other stain removers.
I asked two different clerks, in French, if they knew where it was and they couldn't find it. My French isn't great, though, so who knows what they actually thought I was asking for..
Agree with the frustration, TH.... who cares about a single gas station in NZ? I KNOW it represents more than one gas station, but.... it is only one gas station, in New Zealand.
Please, do elaborate :)
Sheff Station Certified: AEMD
Moving toward large scale production/commercialization!
Aethlon Medical Initiates Relationship to Establish Large Scale Production of Hemopurifier(R) Affinity Agents
Source: Aethlon Medical, Inc.
On Tuesday September 22, 2009, 8:00 am EDT
SAN DIEGO, Sept. 22 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD - News) today announced that it has initiated a relationship with Kentucky Bioprocessing LLC to establish processes to support large-scale production of the active affinity agents immobilized within the Aethlon Hemopurifier®. Such affinity agents allow the Hemopurifer® to selectively capture a broad-spectrum of viruses from blood and other fluids. The Hemopurifier® is the first-in-class medical device to selectively adsorb viruses and immunosuppressive particles from the bloodstream.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)
"The relationship with Kentucky Bioprocessing represents an important step towards establishing the long-term commercial feasibility of our Hemopurifier®, stated Aethlon Medical CEO, Jim Joyce. "Beyond a significant cost reduction of our affinity agents, the relationship offers large yield production potential in time frames that could improve our response capability against viral outbreaks, including unforeseen bioterror and pandemic threats," concluded Joyce.
As part of the relationship, Kentucky Bioprocessing will establish and confirm the sequence of Aethlon's affinity agents and then conduct optimization studies to insure agent purity. The affinity agents will then be transported as cloned proteins to be expressed in and extracted from tobacco plants as a strategy to maximize production yields.
About Kentucky Bioprocessing LLC
Kentucky Bioprocessing (KBP) is a service provider in the biotechnology industry specializing in the expression, extraction and purification of proteins and other high value products from plants. We work with clients to develop and implement scalable and regulatory compliant production processes designed to result in commercially viable end products. Operating from our one of a kind facility located in Owensboro, Kentucky KBP combines a robust intellectual property portfolio with a professional team experienced in successfully producing dozens of proteins in both stable transgenic and transient plant based gene expression systems. Whether you are considering an expression method for a target protein or are in need of process development and production services, our experience and know how can help you to avoid costly and time consuming mistakes and speed the commercialization process. Additional information is available online at www.kbpllc.com
About Aethlon Medical
Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.
I think it's just 1 new location.. 37 different locations for the company, but this one particular franchise is now selling WC... correct me if i'm wrong.
It was one of the best I've ever played, along with this one (new video!):
http://vimeo.com/channels/inthewest
Agreed. If only we were all viral marketing gurus.
We should certainly try to spread this news around Ihub.. if people see the product on their own tv there will be new interest from old investors (short and long) who have since moved on.
Nice, keep me posted.
Exciting stuff GWMAN, but I'm getting restless! I want to be rich already ;)
Such is the story with most people on Ihub, at least.. I will maintain my position of having patience with AEMD.
If this hits the low .20's I may significantly increase my position again.
Accredited Members, Inc. ("AMI") announces the agenda for its fall 2009 micro cap / small cap investment conference. The conference will be held September 28 and 29, 2009 at the Broadmoor Resort in Colorado Springs, Colorado. The following is a list of the presenting companies:
Aethlon Medical, Inc. (OTCBB:AEMD), Biz Radio (Private), Caddis Capital (Private), DRI Corporation (Nasdaq:TBUS), Galaxy Gaming, Inc. (OTCBB:GLXZ), GelTech Solutions, Inc. (OTCBB:GLTC), La Cortez Energy, Inc. (OTCBB:LCTZ), Omni Bio Pharmaceutical, Inc. (OTCBB:OMBP), Pacific Health Laboratories Inc. (OTCBB:PHLI), PAR Technology Corp. (NYSE:PTC), St. Renatus, LLC (Private), US Silver Corp. (CDNX:USA), WaferGen Biosystems (OTCBB:WGBS), Xtraordinary Sports Facility (Private), and ZAGG Inc. (OTCBB:ZAGG).
Accredited Members, Inc. is a subscription-based, members-only online community dedicated to micro cap and small companies, both public and private. Its research is proprietary to its membership community. AMI's conferences are invitation-only events.
For more information regarding Accredited Members, Inc., go to www.accreditedmembers.com
The Accredited Members Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6576
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Accredited Members, Inc.
CONTACT: Accredited Members, Inc.
Kristeen Colgin
719-265-5821
I'm not saying I DO think this is the case, but I wonder if the lack of price movement after milestone PR's (such as yesterdays) will motivate Eric to start thinking about that buyback or a higher exchange, or at least financials as promised..
Aethlon Medical Releases Shareholder Letter
On Tuesday September 15, 2009, 8:00 am EDT
SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc., (OTC Bulletin Board: AEMD - News) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)
To our Shareholders:
In advance of tomorrow's annual meeting, I wish to thank those
shareholders who returned proxies supporting measures to re-elect our
board of directors, reappoint our auditors, and increase the authorized
shares of our common stock. The results of your votes will be tabulated
during our meeting and disclosed shortly thereafter.
I would also like to take this opportunity to disclose that our
manufacturing program with Bioserv/NextPharma Technologies is now
underway, and that infectious disease researchers have provided initial
verification that our Hemopurifier® is able to capture the emerging H1N1
swine flu virus. We are additionally honored to reestablish a cooperative
research and development agreement with the U.S. Army Medical Research
Institute of Infectious Diseases (USAMRIID) that will continue our
research into treating Ebola and other highly lethal pathogens.
While I am pleased we have advanced these initiatives, our primary focus
remains directed towards leveraging our therapeutic opportunity in
Hepatitis-C care and establishing strategic relationships that will
maximize long-term economic value for shareholders. In this regard, we
are actively pursuing relationships that offer to augment or
significantly expand our clinical, distribution, and manufacturing
capabilities. However, I want to stress the complexity underlying any
such relationship should not be underestimated. We face issues that
include competition between players in the medical device space, scaling
of manufacturing at feasible costs, and developing appropriate
distribution channels in a variety of markets. Additionally, we maintain
a firm stance that Aethlon Medical shareholders should maintain 100%
ownership of our Hemopurifier® technology. Regardless of these
challenges, I am increasingly confident that we will establish
relationships that provide us the foundation to transition our science
into a successful business enterprise.
On behalf of our dedicated team at Aethlon Medical, I thank you for your
continued support and look forward to meeting those of you who attend
tomorrow's meeting.
Very truly yours,
James A. Joyce
Chairman, CEO
Certain of the statements within this shareholder letter may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products and provide its services, the Company's ability to forge corporate partnerships on terms acceptable to the Company or at all, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
Jon Cunningham
RedChip Companies Inc.
(407) 644-4256
(407) 491-4498 -cell
Dave@redchip.com or Jon@redchip.com
Jim Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Senior VP Finance
858.459.7800 x300
jfrakes@aethlonmedical.com
C'mon people, WAKE UP! WNBD sure will today...
Did the breakfast club pass out?
http://www.youtube.com/watch?v=796jG5qiDEA
As many of you know, I've been here a long time and read every post but don't post often myself... do my part behind the scenes like most of you promoting the product around the Boston/Cambridge area.
I just wanted to pop in to say awesome news! A definite green-day PR... 1/6 of the # of stores we wanted from the listing, but it's a real national banner with name recognition, in a completely new sector.. one in which all of the WB products would thrive (Kind, anyone?).. this is a significant milestone, IMO.
Are you surprised by the action today after the news? I'm still doing DD on this, obviously, but I am not taking your glowing endorsement lightly :)
The PR stated they had to increas the authorized shares in order to pay STS.. does that mean they're all issued and the OS is close to the AS?
Too late to get in? I know you're long, but just how long do you expect to hold EVRM?
Hey guys - here's some disc golf footage from my trip out west..
http://www.vimeo.com/6495649
Maybe this has something to do with it?
http://www.mhconnect.com/
I think we're due for something this week, shareholder letter or press release.. there's a lot in the pipeline right now, we just need another substantial update
oh yea? What could that be? ;) (thanks)
I just talked to Louis Ramos from Redchip. He registered me for the Redchip investor conference that is being hosted and sponsored by Nasdaq in NYC on Sept. 30th.
I would encourage anyone else interested in attending to call Louis at 1-800-733-2447 x118.
I'm not 100% sure I'll be able to make it yet, but regisration is free ahead of time whereas if you wait to register you'll have to pay if you just show up hoping to get in.
Louis is also sending me the full Redchip Due Diligence package (although I'm fairly certain I won't find anything new, one can't have enough DD)
Lol, St Vincent is a bit obscure, I'll concede that one.. but Spoon and Wilco are heavyweights in the indie/alternative rock world, and if you don't know them yet, you should :)
Thanks, I must've still been seeing PM numbers.
.3 on the ask? is it stacked thick?
She has over 7000 friends on Myspace... and we were excited about Marc Hill having 300 followers, remember? This is part of Eric's plan to cover many media outlets, IMO... maybe we can get product placement in her videos.
Her myspace profile has over 4.1 million views... nothing to sneeze at.
We've been bouncing around between 25-30 for two months, now.. the low end of the range is a safe place to buy, IMO.. Not to mention a few pennies here and there might make no difference with how much potential there is here. I'm still looking for an opportunity to double up - this may be the time.
Awesome, NEPH in the 2.20's
I don't see anything there that would suggest the potential of the hemopurifier has changed.. do you?
except maybe the lack of a major announcement?
I agree it's not fun to watch, but I also don't want bad news.. I'm holding for much bigger swings than we're seeing between .25-.35
There you go... time to load up!
All the buys at the ask again today?
The redchip report is pretty extensive..
Redchip does a nice job with coverage...
http://www.redchip.com/visibility/investor.asp?symbol=AEMD
Thanks GW, do you know how I can hear these broadcasts?
Nothing for sale below .3...
This is going to be fun in the coming months!
I don't think it's a coincidence that they chose the video where scup says:
"I can't wait for this to hit the states full force, which many of us know it's going to. It's a publically traded company..."
.3 seems like a pretty solid base.. I might think about doubling up here this week